Multiple Manufacturers

CANCIDAS

Manufacturer:

Multiple Manufacturers

Cancidas HCPCS:

J0637

HCPCS Code Descriptor:

Injection, caspofungin acetate, 5 mg

Category:

J Code

Cancidas NDCs:

63323-0358-10, 63323-0356-10, 00006-3823-10, 00006-3822-10, 70860-0107-10, 70860-0106-10, 67457-0832-70, 00781-3423-94, 72611-0702-01, 72266-0107-01, 47781-0614-07, 67457-0831-50, 00781-3421-94, 72611-0700-01, 47781-0613-07, 25021-0195-10, 72266-0106-01, 25021-0194-10

Primary Type:

Anti-Fungal

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

70860-0107-10, 70860-0106-10, 67457-0832-70, 72611-0702-01, 47781-0614-07, 72266-0107-01, 67457-0831-50, 47781-0613-07

About Cancidas:

CANCIDAS is an Anti-Fungal drug manufactured by Merck and administered via the Intravenous route of administration. The J Code: J0637 is aligned to the drug CANCIDAS.

ACCESS PRICING AND MORE BY REGISTERING

J0637 Added Date:

January 1, 2003

J0637 Effective Date:

January 1, 2003

J0637 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cancidas billing and coding information.
Our team did not identify a source for Cancidas patient assistance information. Please reach out to our team if you feel that this is a mistake.
CANCIDAS prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for CANCIDAS. Please check back in a few weeks.